abstract |
Disclosed is use/usage of an activin receptor-like kinase 1 (ALK1) inhibitor in a pharmaceutical composition for preventing vascular disorders. Specifically disclosed are: a pharmaceutical composition for preventing vascular disorders, which contains an ALK1 inhibitor as an active ingredient; and a method for treating vascular disorders using the pharmaceutical composition. |